Visgo Therapeutics Overview
- Year Founded
-
2013

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Visgo Therapeutics General Information
Description
Developer of medical therapies designed to treat joint disease such as osteoarthritis (OA). The company's medical therapies are microparticle that can be loaded with drugs and delivered by intra-articular (IA) injection for release over time within the joint, with minimal systemic exposure, enabling patients to get relief from joint pain and osteoarthritis.
Contact Information
Website
www.visgotx.comCorporate Office
- 67 South Bedford Street
- Suite 400W
- Burlington, MA 01803
- United States
Corporate Office
- 67 South Bedford Street
- Suite 400W
- Burlington, MA 01803
- United States
Visgo Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Jul-2017 | Completed | Out of Business | |||
1. Angel (individual) | 05-Mar-2015 | Completed | Startup |
Visgo Therapeutics Comparisons
Industry
Financing
Details
Visgo Therapeutics Competitors (12)
One of Visgo Therapeutics’s 12 competitors is Xalud Therapeutics, a Venture Capital-Backed company based in New York, NY.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Xalud Therapeutics | Venture Capital-Backed | New York, NY | ||||
DiaMedica Therapeutics | Formerly VC-backed | Minneapolis, MN | ||||
Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
Voyager Therapeutics | Corporation | Lexington, MA | ||||
Escient Pharmaceuticals | Formerly VC-backed | San Diego, CA |
Visgo Therapeutics Patents
Visgo Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2016209477-A1 | Injectable aggregates for joint and soft tissue distress | Inactive | 20-Jan-2015 | ||
EP-3247462-A1 | Injectable aggregates for joint and soft tissue distress | Inactive | 20-Jan-2015 | ||
US-20180000737-A1 | Injectable aggregates for joint and soft tissue distress | Inactive | 20-Jan-2015 | ||
EP-3247462-A4 | Injectable aggregates for joint and soft tissue distress | Inactive | 20-Jan-2015 | A61K9/146 |
Visgo Therapeutics FAQs
-
When was Visgo Therapeutics founded?
Visgo Therapeutics was founded in 2013.
-
Where is Visgo Therapeutics headquartered?
Visgo Therapeutics is headquartered in Burlington, MA.
-
What industry is Visgo Therapeutics in?
Visgo Therapeutics’s primary industry is Pharmaceuticals.
-
Is Visgo Therapeutics a private or public company?
Visgo Therapeutics is a Private company.
-
What is Visgo Therapeutics’s current revenue?
The current revenue for Visgo Therapeutics is
. -
How much funding has Visgo Therapeutics raised over time?
Visgo Therapeutics has raised $725K.
-
Who are Visgo Therapeutics’s competitors?
Xalud Therapeutics, DiaMedica Therapeutics, Pfizer Pakistan, Voyager Therapeutics, and Escient Pharmaceuticals are some of the 12 competitors of Visgo Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »